Abstract
Objectives: To compare Gd-EOB-enhanced MRI and 99mTc-mebrofenin hepatobiliary scintigraphy (HBS) as imaging-based liver function tests for separate evaluation of right (RLL) and left liver lobe (LLL) function.
Methods: Fourteen patients underwent Gd-EOB-enhanced MRI and 99mTc-mebrofenin HBS after portal vein embolization within 24 h. Relative enhancement (RE) and hepatic uptake index (HUI) were determined from MRI; and Tmax, T1/2 and mebrofenin uptake were determined from HBS, all values separately for RLL and LLL.
Results: Mebrofenin uptake correlated significantly with HUI and RE for both liver lobes. There was strong correlation of mebrofenin uptake with HUI for RLL (r2 = 0.802, p = 0.001) and RE for LLL (r2 = 0.704, p = 0.005) and moderate correlation with HUI for LLL (r2 = 0.560, p = 0.037) and RE for RLL (r2 = 0.620, p = 0.018). Correlating the percentage share of RLL function derived from MRI (with HUI) with the percentage of RLL function derived from mebrofenin uptake revealed a strong correlation (r2 = 0.775, p = 0.002).
Conclusions: Both RE and HUI correlate with mebrofenin uptake in HBS. The results suggest that Gd-EOB-enhanced MRI and 99mTc-mebrofenin HBS may equally be used to separately determine right and left liver lobe function.
Key points: • Information about liver function can be acquired with routine Gd-EOB-MRI.
• Gd-EOB-MRI and99mTc-mebrofenin HBS show elevated function of non-embolized lobe.
• Gd-EOB-MRI and99mTc-mebrofenin HBS can determine lobar liver function.
Original language | English |
---|---|
Pages (from-to) | 1384-1391 |
Number of pages | 8 |
Journal | European Radiology |
Volume | 25 |
Issue number | 5 |
DOIs | |
State | Published - May 1 2015 |
Keywords
- EOB
- Gadoxetic acid
- Liver function
- Mebrofenin scintigraphy
- MRI